Mo1532 Feasibility and Usefullness of Application of Oxidized Cellulose (Surgicell) to Treat and Prevent Hemorrhage After Large Endosocpic Colorectal Resections Seiichiro Abe*, Ivan Jovanovic, Helmut Neumann, Yutaka Saito, Monkemuller Klaus Endoscopy, National Cancer Center, Tokyo, Japan; Basil I. Hirschowitz Endoscopic Center of Excellence, University of Alabama, Birmingham, AL Background: The most common complication of endoscopic resection (ER) of large colorectal polyps is bleeding, especially in patients who must continue anticoagulation medications for thrombophilic or cardiovascular disorders. Oxidized cellulose (OC) mesh (Surgicell ) is a well-known and widely available surgical hemostatic agent. OC, which has bactericidal activity, exerts its effect as a tissue-apposing device. OC is used to stop bleeding from liver lacerations, gynecological surgery and in neurosurgical interventions. Therefore, it use in endoluminal GI interventions is appealing. Aim: To evaluate the feasibility of endoscopic application of OC and the hemostatic efficacy after endoscopic resection (endoscopic submucosal dissection or piecemeal endoscopic mucosal resection). Materials and Methods: Retrospective, observational, open label, single-center study of patients undergoing endoscopic resection of large rectal and rectosigmoid lesions. After the colorectal epithelial neoplasm removed, OC was applied onto the submucosal surface using one of two methods: a) anoscope or cap-assisted delivery. In both techniques, a hemoclip was advanced through the working channel of the scope and 10 x 10 to 20 x 20 mm large pieces of the OC were grasped with the clip and then delivered and attached to the wound. Results: A total of 12 patients (8 male, 4 female, mean age 64, range 48 to 87) underwent endoscopic resection (ESD, nZ8 or piecemeal EMR, nZ4) of large rectum or rectosigmoid lesions with either primary intent of complete resection or debulking (in the case of large mucin-secreting rectal tumors). All patients were on anticoagulants and/or antiplatelet agents. The mean size of the lesions was 40 mm, range 30 to 120 mm. An endoscopic R0 was achieved in 75%. (50.0%) underwent the Surgicell application. During follow-up period there were no rectal bleeding episodes or adverse events, despite patients continuing on anticoagulant therapy. Conclusions: OC can be successfully applied to large resection sites using the capassisted or anoscope techniques. OC effectively decreases hemorrhage and prevents post-endoscopic resection bleeding. Thus, this feasibility study suggests that OC may be a valuable tool to provide hemostasis and prevent bleeding after ESD. Now prospective and randomized studies are warranted.
Read full abstract